Table 1 In vitro MIC and FICI values for treatments against Gram-negative bacterial strains.
Species | FICIpolB/net Range | MICpolB (A1) | CompolB(A2) | MICpolB/net Range | MICnet (B1) | Comnet(B2) | MICnet/polB Range |
---|---|---|---|---|---|---|---|
A. baumanii, clinical isolates (YCSAb5, 7) and colistin resitant clinical isolates (YCRAb49, 257, 269, 301, 615) | |||||||
 A. baumannii ATCC15150 | 0.25 | 2 | 0.25 | 0.001953–0.5 | 200 | 25 | 3.125–100 |
 A. baumanii YCSAb5 | 0.375 | 1 | 0.25 | 0.125–0.25 | 200 | 25 | 3.2–100 |
 A. baumanii YCSAb7 | 0.375 | 2 | 0.25 | 0.125–1 | 200 | 50 | 12.5–100 |
 A. baumanii YCRAb49 | 0.75 | 16 | 8 | 8 | 800 | 200 | 200–400 |
 A. baumanii YCRAb257 | 0.266 | 16 | 4 | 0.125–2 | 200 | 3.125 | 12.5–100 |
 A. baumanii YCRAb269 | 0.508 | 8 | 4 | 0.25–2 | 400 | 3.125 | 3.125–100 |
 A. baumanii YCRAb301 | 0.508 | 8 | 4 | 0.5–2 | 400 | 3.125 | 3.125–200 |
 A. baumanii YCRAb615 | 0.508 | 8 | 4 | 0.125–2 | 400 | 3.125 | 3.125–200 |
Commensal and human pathogenic Gram-negative bacteria | |||||||
 E. coli MG1655 | 0.375 | 1 | 0.125 | 0.0625–0.125 | 50 | 12.5 | 0.098–25 |
 S. flexneri SF2a | 0.75 | 1 | 0.25 | 0.125–0.5 | 12.5 | 6.25 | 3.125–6.25 |
 S. typhimurium LT2 | 0.625 | 4 | 0.5 | 0.250–0.5 | 25 | 12.5 | 6.25–12.5 |
 P. aeruginosa PA14 | 1 | 1 | 0.5 | 0.5–1 | 400 | 200 | 400–200 |
 P. aeruginosa YPa2 | 1.004 | 2 | 2 | 2 | 800 | 3.125 | 800 |